Abstract
The EWS family of genes is involved in numerous chromosomal translocations that are characteristic of a variety of sarcomas. A recently described member of this group is desmoplastic small round cell tumor (DSRCT), which is characterized by a recurrent t(11;22)(p13;q12) translocation that fuses the 5′ exons of the EWS gene to the 3′ exons of the WT1 gene. The originally described chimera comprises exons 1–7 of EWS and exons 8–10 of WT1. We have previously reported that the WT1 protein represses the expression of the IGF-I receptor gene, whereas the EWS(1–7)-WT1(8–10) fusion protein activates IGF-I receptor gene expression. It has recently become apparent that EWS-WT1 chimeras produced in DSCRT are heterogeneous as a result of fusions of different regions of the EWS gene to the WT1 gene. We have recently characterized additional EWS-WT1 translocations that involve the juxtaposition of EWS exons 7 or 8 to WT1 exon 8, and an EWS-WT1 chimera that lacks EWS exon 6. The chimeric transcription factors encoded by these various translocations differ in their DNA-binding characteristics and their ability to transactivate the IGF-I receptor promoter. These data suggest that the molecular pathology of DSRCT is more complex than previously appreciated, and that this diversity may provide the foundation for predictive genotype-phenotype correlations in the future.
This is a preview of subscription content, access via your institution
Access options
Subscribe to this journal
Receive 50 print issues and online access
$259.00 per year
only $5.18 per issue
Buy this article
- Purchase on Springer Link
- Instant access to full article PDF
Prices may be subject to local taxes which are calculated during checkout
Similar content being viewed by others
Abbreviations
- IGF-I-R:
-
insulin-like growth factor-I receptor
- DSRCT:
-
desmoplastic small round cell tumor
- EWS:
-
Ewing's Sarcoma
- WT:
-
Wilms' tumor
- RT–PCR:
-
reverse transcription polymerase chain reaction
References
Antonescu CR, Gerald WL, Magid MS, Ladanyi M . 1998 Diag. Mol. Pathol. 7: 24–28
Baserga R, Sell C, Porcu P, Rubini M . 1994 Cell Prolif. 27: 63–71
Bosilevac JM, Olsen RJ, Bridge JA, Hinrichs SH . 1999 J. Biol. Chem. 274: 34811–34818
Brodie SG, Stocker SJ, Wardlaw JC, Duncan MH, McConnell TS, Feddersen RM, Williams TM . 1995 Human Pathol. 26: 1370–1374
Chan AS, MacNeill S, Thorner P, Squire J, Zielenska M . 1999 Ped. Dev. Pathol. 2: 188–192
Clark J, Benjamin H, Gill S, Sidhar S, Goodwin G, Crew J, Gusterson BA, Shipley J, Cooper CS . 1996 Oncogene 12: 229–235
Cohick WS, Clemmons DR . 1993 Ann. Rev. Physiol. 55: 131–153
Delattre O, Zucman J, Plougastel B, Desmaze C, Melot T, Peter M, Kovar H, Joubert I, de Jong P, Rouleau G, Aurias A, Thomas G . 1992 Nature 359: 162–165
El-Badry OM, Minniti C, Kohn EC, Houghton PJ, Daughaday WH, Helman LJ . 1990 Cell Growth Differ. 1: 325–331
Gansler T, Furlanetto R, Gramling TS, Robinson KA, Blocker N, Buse MG, Sens DA, Garvin AJ . 1989 Am. J. Pathol. 135: 961–966
Gerald WL, Miller HK, Battifora H, Miettinen M, Silva EG, Rosai J . 1991 Am. J. Surg. Pathol. 15: 499–513
Gerald WL, Rosai J, Ladanyi M . 1995 Proc. Natl. Acad. Sci. USA 92: 1028–1032
Gill S, McManus AP, Crew AJ, Benjamin H, Sheer D, Gusterson DA, Pinkerton CR, Patel K, Cooper CS, Shipley JM . 1995 Genes Chromos. Cancer 12: 307–310
Gonzalez-Crussi F, Crawford SE, Sun CC . 1990 Am. J. Surg. Pathol. 14: 633–642
Grimberg A, Cohen P . 2000 J. Cell. Physiol. 183: 1–9
Haber DA, Sohn RL, Buckler AJ, Pelletier J, Call KM, Housman DE . 1991 Proc. Natl. Acad. Sci. USA 88: 9618–9622
Jeon IS, Davis JN, Braun BS, Sublett JE, Roussel MF, Denny CT, Shapiro DN . 1995 Oncogene 10: 1229–1234
Karnieli E, Werner H, Rauscher III FJ, Benjamin LE, LeRoith D . 1996 J. Biol. Chem. 271: 19304–19309
Kim J, Lee K, Pelletier J . 1998 Oncogene 16: 1973–1979
Kuroda M, Ishida T, Horiuchi H, Kida N, Uozaki H, Takeuchi H, Tsuji K, Imamura T, Mori S, Machinami R . 1995 Am. J. Pathol. 147: 1221–1227
Ladanyi M . 1995 Diag. Mol. Pathol. 4: 162–173
Ladanyi M, Gerald W . 1994 Cancer Res. 54: 2837–2840
LeRoith D, Werner H, Beitner-Johnson D, Roberts Jr CT . 1995 Endocrine Rev. 16: 143–163
Liu J, Nau MM, Yeh JC, Allegra CJ, Chu E, Wright JJ . 2000 Clin. Cancer Res. 6: 3522–3529
Maor SB, Abramovitch S, Erdos MR, Brody LC, Werner H . 2000 Mol. Gen. Metab. 69: 130–136
Ohlsson C, Kley N, Werner H, LeRoith D . 1998 Endocrinology 139: 1101–1107
Ohno T, Ouchida M, Lee L, Gatalica Z, Rao VN, Reddy ES . 1994 Oncogene 9: 3087–3097
Ouchida M, Ohno T, Fujimura Y, Rao VN, Reddy ES . 1995 Oncogene 11: 1049–1054
Plougastel B, Zucman J, Peter M, Thomas G, Delattre O . 1993 Genomics 18: 609–615
Rabbitts TH . 1994 Nature 372: 143–149
Rauscher III FJ . 1993 FASEB J. 7: 896–903
Rauscher III FJ, Benjamin LE, Fredericks WJ, Morris JF . 1994 Cold Spring Harbor Symp. Quant. Biol. 59: 137–146
Resnicoff M, Burgaud J-L, Rotman HL, Abraham D, Baserga R . 1995 Cancer Res. 55: 3739–3741
Sawyer JR, Tryka AF, Lewis JM . 1992 Am. J. Surg. Pathol. 16: 411–416
Shimizu Y, Mitsui T, Kawakami T, Ikegami T, Kanazawa C, Katsuura M, Obata K, Yamagiwa I, Hayasaka K . 1998 Cancer Genet. Cytogenet. 106: 156–158
Tajinda K, Carroll J, Roberts Jr CT . 1999 Endocrinology 140: 4713–4724
Werner H, Adamo M, Roberts Jr CT, LeRoith D . 1994a Vitamins and Hormones Vol. 48: Litwack G (ed.) Academic Press: San Diego, CA pp 1–58
Werner H, Bach MA, Stannard B, Roberts Jr CT, LeRoith D . 1992 Mol. Endocrin. 6: 1545–1558
Werner H, Karnieli E, Rauscher III FJ, LeRoith D . 1996a Proc. Natl. Acad. Sci. USA 93: 8318–8323
Werner H, LeRoith D . 1996 Adv. Cancer Res. 68: 183–223
Werner H, LeRoith D . 1997 Crit. Rev. Oncogenesis 8: 71–92
Werner H, Rauscher III FJ, Sukhatme VP, Drummond IA, Roberts Jr CT, LeRoith D . 1994b J. Biol. Chem. 269: 12577–12582
Werner H, Re GG, Drummond IA, Sukhatme VP, Rauscher III FJ, Sens DA, Garvin AJ, LeRoith D, Roberts Jr CT . 1993 Proc. Natl. Acad. Sci. USA 90: 5828–5832
Werner H, Roberts Jr CT, Rauscher III FJ, LeRoith D . 1996b J. Mol. Neurosci. 7: 111–123
Werner H, Shen-Orr Z, Rauscher III FJ, Morris JF, Roberts Jr CT, LeRoith D . 1995 Mol. Cell. Biol. 15: 3516–3522
Zucman J, Delattre O, Desmaze C, Epstein AL, Stenman G, Speleman F, Fletchers CD, Aurias A, Thomas G . 1993a Nature Genet. 4: 341–345
Zucman J, Delattre O, Desmaze C, Plougastel B, Joubert I, Melot T, Peter M, De Jong P, Rouleau G, Aurias A, Thomas G . 1992 Genes Chromosomes Cancer 5: 271–277
Zucman J, Melot T, Desmaze C, Ghysdael J, Plougastel B, Peter M, Zucker JM, Triche TJ, Sheer D, Turc-Carel C . 1993b EMBO J. 12: 4481–4487
Acknowledgements
This work was performed in partial fulfillment of the requirements for the MSc degree by Ina Finkeltov, in the Sackler Faculty of Medicine, Tel Aviv University. HW is the recipient of a Guastalla Fellowship from the Rashi Foundation, Israel. This work was supported by a grant from the Israel Cancer Association to H Werner and by NIH grant DK50810 to CT Roberts.
Author information
Authors and Affiliations
Corresponding author
Rights and permissions
About this article
Cite this article
Finkeltov, I., Kuhn, S., Glaser, T. et al. Transcriptional regulation of IGF-I receptor gene expression by novel isoforms of the EWS-WT1 fusion protein. Oncogene 21, 1890–1898 (2002). https://doi.org/10.1038/sj.onc.1205042
Received:
Revised:
Accepted:
Published:
Issue Date:
DOI: https://doi.org/10.1038/sj.onc.1205042
Keywords
This article is cited by
-
Oncogenic fusion proteins adopt the insulin-like growth factor signaling pathway
Molecular Cancer (2018)
-
Antiangiogenic effects in patients with progressive desmoplastic small round cell tumor: data from the French national registry dedicated to the use of off-labeled targeted therapy in sarcoma (OUTC’s)
Clinical Sarcoma Research (2017)
-
Lost miRNA surveillance of Notch, IGFR pathway—road to sarcomagenesis
Tumor Biology (2014)
-
Desmoplastic small round cell tumour: characteristics and prognostic factors of 41 patients and review of the literature
Clinical Sarcoma Research (2013)
-
Tumor suppressors govern insulin-like growth factor signaling pathways: implications in metabolism and cancer
Oncogene (2012)